OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-11 Cr | ₹-8.73 Cr | ₹1.66 Cr | ₹1.46 Cr | ₹1.34 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-11 Cr |
| Mar2024 | ₹-8.73 Cr |
| Mar2023 | ₹1.66 Cr |
| Mar2022 | ₹1.46 Cr |
| Mar2021 | ₹1.34 Cr |
How is Deferred Tax Assets / Liabilities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-11 Cr | Negative | |
| Mar2024 | ₹-8.73 Cr | Negative | |
| Mar2023 | ₹1.66 Cr | 13.55 | |
| Mar2022 | ₹1.46 Cr | 9.03 | |
| Mar2021 | ₹1.34 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹194.6 Cr | -3% | -7.7% | -41.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -3% |
-7.7% |
-41.6% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses